🟢 Neuronetics is trading 5% up today after revenue beat and first positive adjusted EBITDA

Neuronetics is trading 5% up now at $3.19 after investors continued responding to its August 11 earnings release.

• Second-quarter revenue reached $41.6 million, ahead of expectations, while adjusted EBITDA turned positive at $0.3 million for the first time.
• Management narrowed full-year revenue guidance to $160–$164 million and raised gross-margin targets.
• NeuroStar technology revenue declined 2.7%.